• 제목/요약/키워드: Parameters Sensitivity

검색결과 2,066건 처리시간 0.029초

내원 초기에 측정한 외상환자의 동맥혈 염기결핍의 유용성 (The Usefulness of Initial Arterial Base Deficit in Trauma Patients)

  • 이은헌;최재영;최영철;황성연
    • Journal of Trauma and Injury
    • /
    • 제19권1호
    • /
    • pp.67-73
    • /
    • 2006
  • Purpose: The arterial base deficit (BD) has proven to be useful in the evaluation and management of trauma patients. Indicators such as the Triage-Revised Trauma Score (t-RTS) and the systemic inflammatory response syndrome (SIRS) score have been used as triage tools for emergency trauma patients in Korea. The purpose of this study was to assess the usefulness of the initial BD in predicting injury severity and outcome in the trauma population. Methods: The medical records of 308 consecutive trauma patients admitted to the Emergency Center of Masan Samsung Hospital from January 2004 to December 2004 were carefully examined prospectively and retrospectively, and 291 patients were selected as subjects for this research. The SIRS score and the t-RTS were calculated based on the records from the emergency department, and the BD was calculated based on the arterial blood gas analysis obtained within 30 minutes of admission. The efficiency of the three indicators as triage tools was evaluated by using cross tabulations in two - by - two matrices and by using a receiver operating characteristic (ROC) curve analysis. Results: When the mortality was used as the outcome parameter, the sensitivity and the accuracy of the initial BD were higher than those of the SIRS score (p<0.05) and were same as those of the t-RTS. The areas under the ROC curves of the initial BD, the SIRS score, and the t-RTS were $0.740{\pm}0.087$, $0.696{\pm}0.082$, and $0.871{\pm}0.072$, respectively (95% confidence interval). When emergency operation and blood transfusion requirements were used as outcome parameters, the comparisons of the sensitivities and the accuracies of the initial BD and the other two indicators showed the same pattern as mentioned above. The areas under the ROC curves of the initial BD were 0.7~0.8 and were larger than those of the SIRS score (p<0.05). Conclusion: The ability of the initial BD to predict injury severity and outcome was similar to those of the t-RTS and the SIRS score. Therefore, the authors suggest that the initial BD may be used as an alternative to previous triage tools for trauma patients.

터널발파로 인한 굴착선주변 암반거동의 확률론적 연구 (Probabilistic Analysis of Blasting Loads and Blast-Induced Rock Mass Responses in Tunnel Excavation)

  • 이인모;박봉기;박채우
    • 한국지반공학회논문집
    • /
    • 제20권4호
    • /
    • pp.89-102
    • /
    • 2004
  • 디커플링장전조건의 화약 폭발시 발생하는 발파압력은 최대압력, 최대압력 도달시간, 압력파형의 함수로 나타난다. 발파 최대압력과 최대압력 도달시간은 화약과 암반 특성의 함수이다. 화약과 암반특성시험 결과로부터 그 특성치의 확률분포를 산출하였다. 화약과 암반 특성치의 확률분포가 정규분포로 나타났으므로 발파 최대압력과 최대압력 도달시간의 확률분포도 정규분포로 추정되었다. 발파 최대압력과 최대압력 도달시간에 가장 크게 영향을 미치는 변수를 파악하기 위하여 매개변수분석과 불확정성분석을 실행하였다. 최대압력과 최대압력 도달시간은 매개변수분석결과 화약특성에 가장 크게 영향을 받았지만 불확정성분석결과 화약보다 암반특성에 크게 영향을 받았다. 발파로 인하여 굴착선주 변 암반에 발생하는 손상을 수치해석으로 분석하였다. 암반손상을 산정하기 위하여 연속체손상역학에 기초하여 사용자 부 프로그램을 작성하였다. 이 부 프로그램을 ABAQUS 주 프로그램과 연결하여 해석하였다. 동적 해석결과는 확대공 발파에 의한 손상이 외곽공보다 크게 나타났다. 확대공 배치, 암반분류 세분화 등 여굴방지 방안이 제안되었다 손상계수의 파쇄기준이 불명확하므로 fuzzy-random 확률이론을 적용하여 파쇄기준과 파쇄영역을 명확하게 나타내었다.

Comparison of α1-Antitrypsin, α1-Acid Glycoprotein, Fibrinogen and NOx as Indicator of Subclinical Mastitis in Riverine Buffalo (Bubalus bubalis)

  • Guha, Anirban;Guha, Ruby;Gera, Sandeep
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제26권6호
    • /
    • pp.788-794
    • /
    • 2013
  • Mastitis set apart as clinical and sub clinical is a disease complex of dairy cattle, with sub clinical being the most important economically. Of late, laboratories showed interest in developing biochemical markers to diagnose sub clinical mastitis (SCM) in herds. Many workers reported noteworthy alternation of acute phase proteins (APPs) and nitric oxide, (measured as nitrate+nitrite = NOx) in milk due to intra-mammary inflammation. But, the literature on validation of these parameters as indicators of SCM, particularly in riverine milch buffalo (Bubalus bubalis) milk is inadequate. Hence, the present study focused on comparing several APPs viz. ${\alpha}_1$-anti trypsin, ${\alpha}_1$-acid glycoprotein, fibrinogen and NOx as indicators of SCM in buffalo milk. These components in milk were estimated using standardized analytical protocols. Somatic cell count (SCC) was done microscopically. Microbial culture was done on 5% ovine blood agar. Of the 776 buffaloes (3,096 quarters) sampled, only 347 buffaloes comprising 496 quarters were found positive for SCM i.e. milk culture showed growth in blood agar with $SCC{\geq}2{\times}10^5$ cells/ml of milk. The cultural examination revealed Gram positive bacteria as the most prevalent etiological agent. It was observed that ${\alpha}_1$-anti trypsin and NOx had a highly significant (p<0.01) increase in SCM milk, whereas, the increase of ${\alpha}_1$-acid glycoprotein in infected milk was significant (p<0.05). Fibrinogen was below detection level in both healthy and SCM milk. The percent sensitivity, specificity and accuracy, predictive values and likelihood ratios were calculated taking bacterial culture examination and $SCC{\geq}2{\times}10^5$ cells/ml of milk as the benchmark. Udder profile correlation coefficient was also used. Allowing for statistical and epidemiological analysis, it was concluded that ${\alpha}_1$-anti trypsin indicates SCM irrespective of etiology, whereas ${\alpha}_1$-acid glycoprotein better diagnosed SCM caused by gram positive bacteria. NOx did not prove to be a good indicator of SCM. It is recommended measuring both ${\alpha}_1$-anti trypsin and ${\alpha}_1$-acid glycoprotein in milk to diagnose SCM in buffalo irrespective of etiology.

Comparison of the Formula of PSA, Age, Prostate Volume and Race Versus PSA Density and the Detection of Primary Malignant Circulating Prostate Cells in Predicting a Positive Initial Prostate Biopsy in Chilean Men with Suspicion of Prostate Cancer

  • Murray, Nigel P;Reyes, Eduardo;Fuentealba, Cynthia;Orellana, Nelson;Morales, Francisca;Jacob, Omar
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권13호
    • /
    • pp.5365-5370
    • /
    • 2015
  • Background: Combining risk factors for prostate cancer into a predictive tool may improve the detection of prostate cancer while decreasing the number of benign biopsies. We compare one such tool, age multiplied by prostate volume divided by total serum PSA (PSA-AV) with PSA density and detection of primary malignant circulating prostate cells (CPCs) in a Chilean prostate cancer screening program. The objectives were not only to determine the predictive values of each, but to determine the number of clinically significant cancers that would have been detected or missed. Materials and Methods: A prospective study was conducted of all men undergoing 12 core ultrasound guided prostate biopsy for suspicion of cancer attending the Hospital DIPRECA and Hospital de Carabineros de Chile. Total serum PSA was registered, prostate volumecalculated at the moment of biopsy, and an 8ml blood simple taken immediately before the biopsy procedure. Mononuclear cells were obtained from the blood simple using differential gel centrifugation and CPCs identified using immunocytchemistry with anti-PSA and anti-P504S. Biopsy results were classed as positive or negative for cancer and if positive the Gleason score, number of positive cores and percent infiltration recorded. Results: A total of 664 men participated, of whom 234 (35.2%) had cancer detected. They were older, had higher mean PSA, PSA density and lower PSA-AV. Detection of CPCs had high predictive score, sensitivity, sensibility and positive and negative predictive values, PSA-AV was not significantly different from PSA density in this population. The use of CPC detection avoided more biopsies and missed fewer significant cancers.Conclusions: In this screening population the use of CPC detection predicted the presence of clinically significant prostate cancer better than the other parameters. The high negative predictive value would allow men CPC negative to avoid biopsy but remain in follow up. The formula PSA-AV did not add to the predictive performance using PSA density.

Serum Peroxiredoxin3 is a Useful Biomarker for Early Diagnosis and Assessemnt of Prognosis of Hepatocellular Carcinoma in Chinese Patients

  • Shi, Liang;Wu, Li-Li;Yang, Jian-Rong;Chen, Xiao-Fei;Zhang, Yi;Chen, Zeng-Qiang;Liu, Cun-Li;Chi, Sheng-Ying;Zheng, Jia-Ying;Huang, Hai-Xia;Yu, Fu-Jun;Lin, Xiang-Yang
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권7호
    • /
    • pp.2979-2986
    • /
    • 2014
  • Background: Recently, peroxiredoxin3 (PRDX3) was identified as a novel molecular marker for the progression of hepatocellular carcinoma (HCC). However, its potential clinical application as a serum marker for the early diagnosis and prognosis of HCC has not been investigated. Methods: PRDX3, alpha-fetaprotein (AFP), and other biochemical parameters were measured in serum samples from 297 Chinese patients, including 96 with HCC, 98 with liver cirrhosis (LC), and 103 healthy controls (HCs). Correlations between serum PRDX3 expression and clinicopathological variables and the relationship between serum PRDX3 expression and prognosis were analyzed. Results: Serum PRDX3 was significantly higher in HCC patients than in the LC and HC groups. The sensitivity and specificity of serum PRDX3 for the diagnosis of HCC were 85.9% and 75.3%, respectively, at a cutoff of 153.26 ng/mL, and the area under the curve was 0.865. Moreover, serum PRDX3 expression was strongly associated with AFP level, tumor diameter, TNM stage, and portal vein invasion. Kaplan-Meier curve analysis revealed that HCC patients with high serum PRDX3 expression had a shorter median survival time than those with low PRDX3 expression. Moreover, serum PRDX3 expression was an independent risk factor for overall survival. The inverse correlation between serum PRDX3 and patient survival remained significant in patients with early-stage HCC and in those with normal serum AFP levels. Conclusions: Serum PRDX3 can be used as a noninvasive biomarker for the diagnosis and/or prognosis of HCC.

Total Serum Bile Acid as a Potential Marker for the Diagnosis of Cholangiocarcinoma without Jaundice

  • Sombattheera, Sutthikan;Proungvitaya, Tanakorn;Limpaiboon, Temduang;Wongkham, Sopit;Wongkham, Chaisiri;Luvira, Vor;Proungvitaya, Siriporn
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권4호
    • /
    • pp.1367-1370
    • /
    • 2015
  • Diagnosis of cholangiocarcinoma (CCA) is difficult when patients do not show jaundice. The aim of this study was to examine the feasibility of using the total serum bile acid (TSBA) level as an aid for the diagnosis of CCA in patients without jaundice. For this purpose, TSBA of the following groups were measured using a Beckman Synchron CX4 clinical chemistry analyzer: 60 cases of CCA with total serum bilirubin ${\leq}2mg/dL$ (low total bilirubin group, LTB); 32 cases of CCA with total serum bilirubin >2 mg/dL (high total bilirubin group, HTB); and 115 healthy controls. Liver function parameters such as serum cholesterol, albumin, alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) were also examined. The results showed that the TSBA of both LTB and HTB groups of the CCA patients were significantly higher than that of the healthy controls. Also, significant correlation was observed between TSBA and total bilirubin levels in the HTB group of CCA patients. However, no such correlation was seen in the LTB group. The cut-off value of TSBA was determined for the LTB group of CCA patients using the receiver operating characteristic curve analysis, and it was $6.05{\mu}mol/L$ with the sensitivity and specificity of 46.7% and 84.4%, respectively. In addition, the ALP level was correlated well with the TSBA level and ALP in HTB group was significantly higher than that of LTB group. Moreover, the combination of high TSBA and high ALP levels gave higher specificity up to 97.4%. TSBA might be useful for the diagnosis of CCA patients without jaundice.

Nrf2 Overexpression Predicts Prognosis and 5-FU Resistance in Gastric Cancer

  • Hu, Xiu-Feng;Yao, Jun;Gao, She-Gan;Wang, Xin-Shuai;Peng, Xiu-Qing;Yang, Yan-Tong;Feng, Xiao-Shan
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권9호
    • /
    • pp.5231-5235
    • /
    • 2013
  • Objective: NF-E2-related factor 2 (Nrf2) is activated in several human malignancies. However, the role of Nrf2 in gastric cancer (GC) remains incompletely understood. In this study, we therefore analyzed associations of Nrf2 expression status with clinical features and chemotherapeutic resistance in GC. Materials and Methods: A total of 186 samples from GC patients who underwent gastrectomy were used for prognostic assessment. A further 142 samples from GC cases who received first-line combination chemotherapy were applied for investigation of chemoresistance. The Nrf2 expression was evaluated by immunohistochemistry in GC samples, and its relationship with clinicopathological parameters and chemotherapy sensitivity was analyzed. The effect of Nrf2 gene silencing on chemotherapy resistance was also examined by cell viability assay in vivo. Results: Of the 186 patients with GC, 104/186 (55.9%) showed high expression for Nrf2. The overexpression of Nrf2 was an independent predictor of overall survival [OS, hazard ratio (HR) 3.9; P=0.011] and disease-free survival (DFS, HR 4.3; P=0.002). The gene silencing of Nrf2 reduced resistance to cell death induced by 5-FU in GC cell lines. Conclusion: Our data show that Nrf2 is an independent prognostic factor in GC. Furthermore, Nrf2 confers resistance to chemotherapeutic drug 5-FU in GC cells. Taken together, Nrf2 is a potential prognostic marker and predictive for 5-FU resistance in GC.

Evaluation of Ascorbic Acid Treatment in Clinical and Subclinical Mastitis of Indian Dairy Cows

  • Naresh, Ram;Dwivedi, S.K.;Swarup, D.;Patra, R.C.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제15권6호
    • /
    • pp.905-911
    • /
    • 2002
  • A study was carried out to assess the therapeutic effect of ascorbic acid in mastitis of dairy cows. The herd with a population of 250-275 lactating cows was screened for clinical and subclinical mastitis for a period of 5 months. Based on inclusion and exclusion criteria, eighteen animals each with clinical and subclinical mastitis in one quarter only were selected as study population. Twelve cows (group A) with normal udder and health were also selected as a healthy control. Clinical mastitis cows were grouped as B (n=12) and C (n=6). Cows of group B were treated with ascorbic acid at 25 mg/kg, subcutaneously for 5 consecutive days and intramammary infusion (Ampicillin sodium 75 mg and Cloxacillin sodium 200 mg/infusion) based on antibiotic sensitivity test, till complete recovery. Group C cows received only intramammary infusion till the complete recovery. Eighteen subclinical mastitis cows were divided in group D (n=12) and E (n=6). Cows of group D were treated with ascorbic acid at 25 mg/kg subcutaneously for 5 consecutive days while group E did not receive any treatment. California mastitis test (CMT), somatic cell count (SCC), physical changes of udder and milk were used to diagnose and classify the mastitis. Evaluation of the therapy was based on CMT score and physical changes of udder and milk. Sample size calculation was also performed but was not followed for control groups due to scarcity of cases. Adequate blinding was done when and where required to avoid the biases. Confounding variables like herd, age of the cow, stage of the lactation, season and geographical region were duly considered and adequate blocking was followed. Ascorbic acid was administered in clinical and subclinical cases even after cure considering its immunostimulatory and healing inducing effects. The recovery rate was faster in cases of clinical mastitis treated with ascorbic acid along with an intramammary infusion (group B) than the quarters of group C cows. Quarter wise the average duration/number (3.16${\pm}$0.11 days) of antimicrobial intramammary infusion was significantly (p<0.01) less in group B than that of average duration/number (5.33${\pm}$0.20 days) of group C. Subclinical mastitis cows treated with ascorbic acid showed 83.33% recovery while 16.77% did not respond to treatment till last day of study. Cows of group E (untreated) did not recovered from the mastitis. Subjective parameters viz. swelling, pain reflex of udder and physical changes in milk from quarter of ascorbic acid treated cows (group B) disappeared earlier than that of group C cows. It is concluded from this study that the ascorbic acid might be useful as an adjunct in case of clinical mastitis to get quick recovery with less number of intramammary infusions. High recovery rate in subclinical mastitis quarters of group D cows is appreciable and opens a new avenue to conduct further trials in a larger population in various field conditions. However, the pharmacology of ascorbic acid with particular reference to health of mammary gland needs to be investigated.

N-Phenyl-O-phenylthionocarbamate 유도체의 항균활성에 미치는 phenyl 치환기의 효과 (Phenyl substituent effect on the fungicidal activity of N-Phenyl-O-phenylthionocarbamate derivatives)

  • 성낙도;성민규
    • 농약과학회지
    • /
    • 제3권1호
    • /
    • pp.29-36
    • /
    • 1999
  • 일련의 N-phenyl-O-phenylthionocarbamate 유도체을 합성하고, benomyl 및 metalaxyl 등 2종의 침투성 살균제에 대하여 저항성과 감수성을 나타내는 잿빛곰팡이병균(Botrytis cinerea) 및 고추 역병균(Phytophthora capsici)에 대한 항균활성(obs. $pI_{50}$)과 치환기 변화에 따른 구조-활성관계(SAR)를 Free-Wilson방법과 Hansch방법으로 검토하였다. 치환기의 기여도는 O-phenyl group (Y)보다 N-phenyl group(X)이 비교적 높았으며 ortho-치환체(X)들이 다른 치환체들에 비해 양호한 항균활성을 나타내었다. 특히 X-치환기로써 4-cyano 치환체, 2는 0.8ppm에서 저항성 고추역병균(RPC)에 대한 균사생장을 50%저해($pI_{50}=5.50$)하였으며 hydroxyl 치환체, 12와 23는 저항성 및 감수성 잿빛 곰팡이균(RBC, SBC)과 감수성 고추역병균(SPC)에 대하여 대체로 높은 항균활성을 나타내었다. SPC균은 MR상수에 의존적인 항균활성을 나타내었고 나머지 3종의 균에 대한 항균활성은 공통적으로 소수성(${\pi}$ 및 logP)에 의존적이었다. 그리고 RPC 및 SBC균의 항균활성을 향상시키기 위한 조건으로는 전자끌게로써 적정값의 ${\sigma}$상수(${\sigma}_{opt.}=0.32$) 및 F상수($F_{opt.}=0.181$)를 갖는 치환기가 치환되어야 항균활성이 개선될 것으로 예상되었다.

  • PDF

Shell 석탄가스화 복합발전 시스템의 성능해석 연구 (Performance Analysis of Shell Coal Gasification Combined Cycle systems)

  • Kim, Jong-Jin;Park, Moung-Ho;Song, Kyu-So;Cho, Sang-Ki;Seo, Seok-Bin;Kim, Chong-Young
    • 에너지공학
    • /
    • 제6권1호
    • /
    • pp.104-113
    • /
    • 1997
  • 본 연구에서는 상용공정모사기인 ASPEN PLUS를 이용하여 건식탄공급, 산소사용 분류층 가스화기인 Shell가스화공정, 저온가스정제공정, GE MS7001FA가스터빈, 삼압.자연순환식 폐열회수보일러, 재열복수식 증기터빈 및 극저온 산소분리공정을 채용한 IGCC시스템에 대하여 성능해석 모델을 개발하고 시스템 성능해석을 위한 민감도분석을 수행하였다. 본 모델의 적정성은 설계조건에서 대상탄을 이용한 정상상태 성능해석 결과를 타 시뮬레이션 결과와 비교함으로서 검증하였다.$^{1)}$ . Illinois#6탄을 대상으로 수행한 시뮬레이션 결과는 투입되는 탄에 함유된 수분의 양이 증가함에 따라 가스화기의 온도가 감소하며, 회분 및 황이 많은 경우에 현열손실이 증가하여 시스템 효율이 감소하였다. 개발된 모델을 이용하여 가스화기의 운전압력, 증기/석탄비율 및 산소/석탄비율에 따르는 시스템의 민감도분석을 수행한 결과 운전압력 증가에 따라 가스화기 노내온도가 상승하며, 가연성가스(CO+H2) 생성율이 감소하였다. 증기/석탄비율 변화분석에서는 공급증기의 양을 변화시키면 가연성가스의 최고생성점이 보다 낮은 산소/석탄비율에서 나타남을 알 수 있었다. 또한 산소/석탄비율 변화분석에서는 증기/석탄 공급비율 0.2에서 산소/석탄 공급비율이 0.77인 경우에 가장 최적의 운전조건임을 알 수 있었다.

  • PDF